Table 3.
Cost components from studies based on data from both patient and provider/system perspectives (mixed)
| Country/study | Diabetes type | Outpatient (per visit) | Cost components, average per person (2016 US$) | ||||
| Outpatient visits (per year) |
Laboratory (per year) | Medicines (per year) | Inpatient (per year) | ||||
| LMICs (n=2) | India51 | 2 | * | 84.40 | 61.57 | 159.86 | 300.54 |
| Nigeria52 | 1 and 2 | 5.97 | 26.88 | 132.87 | 522.85 | * | |
| UMICs (n=5) | Thailand18 | 1 and 2 | 3.99 | 28.26 | 20.20 | 42.85 | 109.42 |
| China53 | 2 | 46.43 | * | * | * | 627.09 | |
| Brazil54 | 2 | * | * | * | 864.86 | * | |
| Brazil55 | 2 | 20.73 | 46.23 | 78.15 | 464.48 | * | |
| Argentina56 | 2 | * | 63.10 | 194.96 | 703.58 | 1081.02 | |
*Authors did not provide data on this cost component.
LMIC, lower middle-income country; UMIC, upper middle-income country.